United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$143Mraised across 5 rounds since 2016, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
SymBiosis
FC CAPITALReported by FinSMEsSEC filing: $8.0M sold, first sale Sept 2019
Gates Foundation
Bristol Myers Squibb
PureTech Health
JSR
Shumway CapitalSymBiosisReported by BusinesswireSEC filing: $45M sold, first sale Dec 2018
Reported by FinSMEsSEC filing: $27M sold, first sale Dec 2018
Rock Springs CapitalReported by Xconomy
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Gates FoundationBristol Myers SquibbSymBiosisInvesco AssetRock Springs
Seventure Partners
Oryx FundRock Springs CapitalPureTech HealthSeventureMissing a round, or an investor who was in one? Tell us.
These 3 firms list Vedanta Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Vedanta Biosciences's investors include Gates Foundation, Bristol Myers Squibb, SymBiosis, Invesco Asset and Rock Springs, and 13 more on record.
Vedanta Biosciences has raised $143M across 5 rounds since 2016.
Vedanta Biosciences's most recent round was a Grant of $3.9M in Apr 2024.
Vedanta Biosciences's largest round on record is $50M (Undisclosed round), in Jun 2016.
Vedanta Biosciences's first round on record, in Jun 2016, was backed by Rock Springs Capital, Health For Life Capital and Invesco Asset Management.
Vedanta Biosciences's latest named round is a Grant, in Apr 2024.
Vedanta Biosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
